R398L (p.Arg398Leu) variant of RASA1 (Ras GTPase-activating protein 1)
R398L (p.Arg398Leu) in RASA1 (Ras GTPase-activating protein 1) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic in the context of Basal cell carcinoma, somatic. The available variant effect predictions contribute to a CATVariant prioritization score of 0.67 / 1. The record also includes published literature and structural context.
R398L (p.Arg398Leu) variant details
- p.Arg398Leu
- rs137853214
- ClinGen CA126139
- ClinVar RCV000017367
- UniProt VAR 002650
- Pathogenic
- Basal cell carcinoma, somatic
- Missense
- Variant Prioritization Score for Impact Estimate 0.666
- AlphaMissense 1.00
- MetaLR 0.67
- MetaSVM 0.37
- PolyPhen-2 1.00
- SIFT 0.01
- MutPred 0.57
- ClinVar: Pathogenic (Basal cell carcinoma, somatic)
- EBI: Pathogenic (in basal cell carcinomas)
- UniProt: Pathogenic (in basal cell carcinomas)
- Structural context available
- Cited in: Nonsense mutations in the C-terminal SH2 region of the GTPase activating protein (GAP) gene in human tumours. (PMID 8275088)